ARTICLE | Distillery Therapeutics
Therapeutics: Vascular endothelial growth factor receptor 3 (FLT4; VEGFR-3); vascular endothelial growth factor C (VEGF-C)
January 14, 2016 8:00 AM UTC
Mouse studies suggest a form of VEGF-C that selectively activates FLT4 signaling could help prevent lung graft rejection. In mice that received lung transplants, allografts undergoing acute rejection ...